1-(3-chloro-5-(trifluoromethyl)phenyl)-2,2,2-trifluoroethan-1-one NEW

‌Afloqualone Intermediate (CAS 1125812-58-9)‌
Google Keywords: Afloqualone Intermediate, CAS 1125812-58-9, Muscle Relaxant Synthesis, Pharmaceutical Intermediates, GMP API Production

🌟 ‌Product Overview‌

‌Afloqualone Intermediate‌ (CAS 1125812-58-9) is a high-purity chemical building block essential for synthesizing ‌Afloqualone‌, a potent muscle relaxant used to treat spasticity and neurological disorders. Designed for API manufacturing, this intermediate ensures efficient and scalable production with strict quality control.

• ‌Primary Function‌: Enables precise synthesis of Afloqualone with controlled impurity levels.

• ‌Applications‌: Muscle relaxant APIs, neurological drug development, and generic formulations.

✅ ‌Key Advantages‌

🔹 ‌Ultra-High Purity‌ | ≥99% (HPLC/GC verified) | Low heavy metal content (<10 ppm).
🔹 ‌Stability‌ | Long shelf life (24 months) under recommended storage conditions.
🔹 ‌GMP Readiness‌ | Compliant with ICH Q7 and ISO 9001 standards for pharmaceutical intermediates.

🧪 ‌Applications‌

1. ‌Muscle Relaxant Production‌: Core component in Afloqualone API synthesis for spasticity management.

2. ‌Neurological Research‌: Supports preclinical studies targeting CNS disorders.

3. ‌Generic Drug Manufacturing‌: Critical for post-patent API scale-up.

📜 ‌Quality Assurance‌

• ‌Testing Methods‌: HPLC, GC, NMR, and ICP-MS for purity and trace element analysis.

• ‌Standards‌: Meets USP/EP specifications for pharmaceutical intermediates.

📈 ‌Market Trends‌

The global muscle relaxant market is projected to grow at ‌6.3% CAGR (2024-2030)‌, fueled by rising demand for non-opioid therapies and neurological disorder treatments. Afloqualone intermediates are vital in addressing unmet needs in spasticity and chronic pain management.

Empower your API production with Afloqualone Intermediate – purity, compliance, and reliability for advanced therapeutics.